Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway

Jarrett T Whelan1, Sarah E Hollis, Dong Seok Cha

  • 1Division of Hematology/Oncology, Department of Medicine, Brody School of Medicine at East Carolina University, Greenville, North Carolina 27834, USA.

Insights

The Ras-ERK/MAPK pathway, vital for cell functions, is regulated post-transcriptionally by RNA-binding proteins and microRNAs. Dysregulation contributes to human cancers.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Genetics

Background:

  • The Ras-ERK/MAP (Mitogen-Activated Protein) kinase pathway is crucial for fundamental cellular processes like proliferation, differentiation, and survival.
  • Aberrant activation of this pathway is frequently implicated in abnormal cell growth and the development of tumors.
  • While post-translational regulation is understood, post-transcriptional control mechanisms are increasingly recognized.

Purpose of the Study:

  • To review the conserved post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway.
  • To highlight the roles of specific RNA-binding proteins and microRNAs in this regulation.
  • To discuss the implications of these regulatory mechanisms in human diseases, particularly cancers.

Main Methods:

  • Literature review of conserved regulatory mechanisms in invertebrates and humans.
  • Focus on RNA-binding proteins including PUF, KH-domain, HuR, and LARP.
  • Analysis of microRNA involvement, specifically the let-7 family.

Main Results:

  • Identified conserved post-transcriptional regulators of Ras-ERK/MAPK signaling.
  • Demonstrated the roles of specific RNA-binding proteins and let-7 family microRNAs.
  • Established the link between these regulatory elements and human pathologies.

Conclusions:

  • Post-transcriptional regulation by RNA-binding proteins and microRNAs is a conserved mechanism controlling Ras-ERK/MAPK signaling.
  • Dysregulation of these factors has significant implications for human diseases, especially cancer.
  • Further research into these pathways may reveal novel therapeutic targets.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...